|
| |
|
Israeli COVID-19 Vaccine Developments Webinar |
|
Start Date: | 5/6/2020 | Start Time: | 12:00 PM |
End Date: | 5/6/2020 | End Time: | 1:00 PM |
|
Event Description: The world awaits a coronavirus cure. Might it come from The Startup Nation? Learn how Israel has mobilized its scientific and technological talents to overcome this modern-day plague, featuring:
• Yaky Yanai, CEO of Pluristem Therapeutics (NASDAQ: PSTI) is working on a placenta-based cell therapy treatment for respiratory and inflammatory complications associated with COVID-19.
• Vered Kaplan, CEO of Orgenesis, (NASDAQ: ORGS) a global biotech company, is unlocking the potential of cell and gene therapy including anti-viral technologies relevant for COVID-19 to provide life changing personalized medical treatments at the point-of-care to patients.
• Dr. Mark Levitt, Medical Director from RedHill Biopharma (Nasdaq: RDHL) a specialty biopharmaceutical company, is working on an experimental drug, Opaganib, which has shown anti-viral and anti-inflammatory properties to help reduce lung inflammation in COVID-19 patients. |
|
Website Link: https://www.eventbrite.com/e/israeli-covid-19-vaccine-developments-webinar-registration-103151480856 |
|
|